Myologie Treatment delay Dystrophie musculaire C2C12 Joint laxity CMTX Diagnosis Lamin A/C Muscular dystrophy MD Myotubes Laminopathies BiP Butyrylcholinesterase Next generation sequencing Emerin LGMD Regeneration Exome Actionable gene Myopathy Myogenesis Gene therapy Heart Angiotensin-converting enzyme inhibitor Base de données FAIR Actionability Dilated cardiomyopathy Lamin A/C nuclei CSF protein Cardiology INPP5K Mouse A-type lamins Rare diseases Autophagosome maturation Lamins Centronuclear myopathy Laminopathy Allele‐specific silencing therapy Congenital muscular dystrophy Laminopathie COL1A1 Cancer Clinical trial Calcium handling COL6A1 Titin Duchenne muscular dystrophy LMNA Skeletal muscle Allele-specific silencing Alternative splicing Dystrophine Cardiac conduction system Maladies rares et orphelines Becker muscular dystrophy Patient registry C elegans Cancer biomarkers Myopathies Rare neuromuscular diseases Cardiomyopathy Muscular dystrophy Mutations COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Adult SMA Ehlers‐Danlos Syndrome LMNA gene Treatment Connective tissue Biomarker A-type lamin LMNA-related congenital muscular dystrophy Muscle MRI Neuromuscular diseases Heart failure Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Hypermobile EDS BVES Lamin A/C LMNA gene Therapy Dynamin 2 AAV VECTOR Nuclear envelope Acetyltransferase CRISPR Muscle biopsy COVID-19 Errance diagnostique Angiotensin-converting enzyme inhibitors AAV Emery-Dreifuss muscular dystrophy Biological sciences Maladies rares POPDC1 IPSC Muscle Allele-specific silencing therapy RNA interference GNE